During the past decade, Brookview Research, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brookview Research, Inc." #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Brookview Research, Inc." are "Endometrial Cancer" (11 trials), "Ovarian Cancer" (10 trials), "Cervical Cancer" (7 trials), "Primary Peritoneal Cavity Cancer" (7 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Brookview Research, Inc." in a lesser frequency.

Most popular intervention types in "Brookview Research, Inc." are "Drug" (28 trials), "Procedure" (6 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (12 trials), "paclitaxel" (8 trials), "radiation therapy" (4 trials), "carboplatin" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Brookview Research, Inc." are 30 trials for "Female" genders.

Currently, there are NaN active trials in "Brookview Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Brookview Research, Inc., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Brookview Research, Inc., 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".